Contact
Please use this form to send email to PR contact of this press release:
Basilea expands oncology drug candidate BAL101553 clinical phase 1/2a oral study to include glioblastoma patients
TO:
Please use this form to send email to PR contact of this press release:
Basilea expands oncology drug candidate BAL101553 clinical phase 1/2a oral study to include glioblastoma patients
TO: